Portfolio company
Neuronostics
United Kingdom · £8.0m raised
Raised
£8.0m
Latest stage
Growth
Rounds recorded
3
Backed by
6 investors
Sectors
About
The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.
SourceFunding history · 3
Similar companies
dEEGtal Insights
The company develops AI-powered software that analyses electroencephalograms to help neurologists and hospitals diagnose epilepsy by detecting patterns invisible to the human eye.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
FIND Neuro
This company develops a clinical decision-support platform that uses brain network analysis to help neurosurgeons identify surgical targets for drug-resistant epilepsy patients.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
Neuro Event Labs Oy
This company develops AI-driven video and audio monitoring systems for detecting and classifying epileptic seizures for neurologists and their patients.
Seer Medical
This company develops wearable devices and software for at-home neurological monitoring to assist clinicians in the diagnosis and management of epilepsy.
Beacon Biosignals
This company develops an analytics platform and hardware to provide electroencephalogram data insights for pharmaceutical firms and medical practitioners.
SEER
This company develops home-based video electroencephalography and electrocardiography monitoring systems to assist healthcare providers and patients with the diagnosis of epilepsy.
